drugset / Trial / NCT01259388
A Pilot Study of Lithium in Progressive Multiple Sclerosis
RandomizedCrossoverSingle-blindTreatment
Summary
The purpose of this study is to determine whether lithium carbonate is safe, well-tolerated, and effective at treating progressive forms of multiple sclerosis.
Timeline
- Start
- 2011-05
- Primary completion
- 2015-08
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lithium Carbonate | Unknown | 150 mg | — |
| Subject | Lithium Carbonate | Unknown | 300 mg | — |